Ferroptosis and its Role in Gastric Cancer

Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Currently, surgery is the treatment of choice for GC. However, the associated expenses and post-surgical pain impose a huge burden on these patients. Furthermore, disease recurrence is...

Full description

Bibliographic Details
Main Authors: Renjun Gu, Yawen Xia, Pengfei Li, Defang Zou, Keqin Lu, Lang Ren, Hongru Zhang, Zhiguang Sun
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.860344/full
_version_ 1811330000621666304
author Renjun Gu
Renjun Gu
Yawen Xia
Yawen Xia
Pengfei Li
Defang Zou
Defang Zou
Keqin Lu
Keqin Lu
Lang Ren
Lang Ren
Hongru Zhang
Zhiguang Sun
Zhiguang Sun
author_facet Renjun Gu
Renjun Gu
Yawen Xia
Yawen Xia
Pengfei Li
Defang Zou
Defang Zou
Keqin Lu
Keqin Lu
Lang Ren
Lang Ren
Hongru Zhang
Zhiguang Sun
Zhiguang Sun
author_sort Renjun Gu
collection DOAJ
description Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Currently, surgery is the treatment of choice for GC. However, the associated expenses and post-surgical pain impose a huge burden on these patients. Furthermore, disease recurrence is also very common in GC patients, thus necessitating the discovery and development of other potential treatment options. A growing body of knowledge about ferroptosis in different cancer types provides a new perspective in cancer therapeutics. Ferroptosis is an iron-dependent form of cell death. It is characterized by intracellular lipid peroxide accumulation and redox imbalance. In this review, we summarized the current findings of ferroptosis regulation in GC. We also tackled on the action of different potential drugs and genes in inducing ferroptosis for treating GC and solving drug resistance. Furthermore, we also explored the relationship between ferroptosis and the tumor microenvironment in GC. Finally, we discussed areas for future studies on the role of ferroptosis in GC to accelerate the clinical utility of ferroptosis induction as a treatment strategy for GC.
first_indexed 2024-04-13T15:53:44Z
format Article
id doaj.art-0d4cf3dea96642b481d6885bc119d34f
institution Directory Open Access Journal
issn 2296-634X
language English
last_indexed 2024-04-13T15:53:44Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cell and Developmental Biology
spelling doaj.art-0d4cf3dea96642b481d6885bc119d34f2022-12-22T02:40:45ZengFrontiers Media S.A.Frontiers in Cell and Developmental Biology2296-634X2022-06-011010.3389/fcell.2022.860344860344Ferroptosis and its Role in Gastric CancerRenjun Gu0Renjun Gu1Yawen Xia2Yawen Xia3Pengfei Li4Defang Zou5Defang Zou6Keqin Lu7Keqin Lu8Lang Ren9Lang Ren10Hongru Zhang11Zhiguang Sun12Zhiguang Sun13Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Provincial Second Chinese Medicine Hospital, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, ChinaDepartment of Clinical Laboratory, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Key Laboratory for Pharmacology and Safety Evaluation of Chinese Materia Medica, School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Collaborative Innovation Center of Traditional Chinese Medicine Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing, ChinaNanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Provincial Second Chinese Medicine Hospital, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaSchool of Basic Medical Sciences, Nanjing University of Chinese Medicine, Nanjing, ChinaNanjing University of Chinese Medicine, Nanjing, ChinaJiangsu Provincial Second Chinese Medicine Hospital, The Second Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, ChinaGastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Currently, surgery is the treatment of choice for GC. However, the associated expenses and post-surgical pain impose a huge burden on these patients. Furthermore, disease recurrence is also very common in GC patients, thus necessitating the discovery and development of other potential treatment options. A growing body of knowledge about ferroptosis in different cancer types provides a new perspective in cancer therapeutics. Ferroptosis is an iron-dependent form of cell death. It is characterized by intracellular lipid peroxide accumulation and redox imbalance. In this review, we summarized the current findings of ferroptosis regulation in GC. We also tackled on the action of different potential drugs and genes in inducing ferroptosis for treating GC and solving drug resistance. Furthermore, we also explored the relationship between ferroptosis and the tumor microenvironment in GC. Finally, we discussed areas for future studies on the role of ferroptosis in GC to accelerate the clinical utility of ferroptosis induction as a treatment strategy for GC.https://www.frontiersin.org/articles/10.3389/fcell.2022.860344/fullferroptosisirongastric cancerROSmicroenvironmentdrug resistance
spellingShingle Renjun Gu
Renjun Gu
Yawen Xia
Yawen Xia
Pengfei Li
Defang Zou
Defang Zou
Keqin Lu
Keqin Lu
Lang Ren
Lang Ren
Hongru Zhang
Zhiguang Sun
Zhiguang Sun
Ferroptosis and its Role in Gastric Cancer
Frontiers in Cell and Developmental Biology
ferroptosis
iron
gastric cancer
ROS
microenvironment
drug resistance
title Ferroptosis and its Role in Gastric Cancer
title_full Ferroptosis and its Role in Gastric Cancer
title_fullStr Ferroptosis and its Role in Gastric Cancer
title_full_unstemmed Ferroptosis and its Role in Gastric Cancer
title_short Ferroptosis and its Role in Gastric Cancer
title_sort ferroptosis and its role in gastric cancer
topic ferroptosis
iron
gastric cancer
ROS
microenvironment
drug resistance
url https://www.frontiersin.org/articles/10.3389/fcell.2022.860344/full
work_keys_str_mv AT renjungu ferroptosisanditsroleingastriccancer
AT renjungu ferroptosisanditsroleingastriccancer
AT yawenxia ferroptosisanditsroleingastriccancer
AT yawenxia ferroptosisanditsroleingastriccancer
AT pengfeili ferroptosisanditsroleingastriccancer
AT defangzou ferroptosisanditsroleingastriccancer
AT defangzou ferroptosisanditsroleingastriccancer
AT keqinlu ferroptosisanditsroleingastriccancer
AT keqinlu ferroptosisanditsroleingastriccancer
AT langren ferroptosisanditsroleingastriccancer
AT langren ferroptosisanditsroleingastriccancer
AT hongruzhang ferroptosisanditsroleingastriccancer
AT zhiguangsun ferroptosisanditsroleingastriccancer
AT zhiguangsun ferroptosisanditsroleingastriccancer